Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 2 boards, counting each seat separately. Longest: Syndax Pharmaceuticals Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Syndax Pharmaceuticals Inc. May 14, 202498.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 4, 2026 | Syndax Pharmaceuticals Inc. | Grant or award | +24,000 | — | — |
| May 19, 2025 | Syndax Pharmaceuticals Inc. | Open-market purchase | +5,000 | $8.99 | $44,950 |
| Feb 5, 2025 | Syndax Pharmaceuticals Inc. | Grant or award | +25,000 | — | — |
| Feb 7, 2024 | Syndax Pharmaceuticals Inc. | Grant or award | +17,000 | — | — |
| Feb 2, 2023 | Syndax Pharmaceuticals Inc. | Grant or award | +16,000 | — | — |
Questions about Martin H. Huber Jr.
What boards is Martin H. Huber Jr. on?
Martin H. Huber Jr. sits on the boards of Actuate Therapeutics Inc. and Syndax Pharmaceuticals Inc.
How long has Martin H. Huber Jr. served on boards?
Our records show at least 4 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.